1. Home
  2. NEON vs BRNS Comparison

NEON vs BRNS Comparison

Compare NEON & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$0.87

Market Cap

27.5M

Sector

Technology

ML Signal

HOLD

Logo Barinthus Biotherapeutics plc

BRNS

Barinthus Biotherapeutics plc

N/A

Current Price

$0.64

Market Cap

24.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEON
BRNS
Founded
1997
2016
Country
Sweden
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.5M
24.1M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
NEON
BRNS
Price
$0.87
$0.64
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$4.00
AVG Volume (30 Days)
296.5K
39.7K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
37.88
N/A
EPS
N/A
N/A
Revenue
$3,108,000.00
N/A
Revenue This Year
$72.74
N/A
Revenue Next Year
$28.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.51
52 Week High
$29.90
$2.91

Technical Indicators

Market Signals
Indicator
NEON
BRNS
Relative Strength Index (RSI) 36.98 44.89
Support Level $0.72 $0.56
Resistance Level $1.05 $0.75
Average True Range (ATR) 0.12 0.05
MACD 0.01 -0.01
Stochastic Oscillator 38.06 27.25

Price Performance

Historical Comparison
NEON
BRNS

About NEON Neonode Inc.

Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.

Share on Social Networks: